BCR-ABL as a target for novel therapeutic interventions.

Abstract

The BCR-ABL oncogene is the result of a reciprocal translocation between the long arms of chromosome 9 and 22 t(9; 22). There is good experimental evidence demonstrating that BCR-ABL is the single causative abnormality in chronic myeloid leukaemia (CML), making it a unique model for the development of molecular targets. In addition to CML, BCR-ABL… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.